{"id":"W3015886911","doi":"10.1111/jdv.16460","title":"Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials","year":2020,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Janssen Research and Development","keywords":"Medicine; Latent tuberculosis; Internal medicine; Concomitant; Adalimumab; Adverse effect; Psoriasis; Tuberculosis; Placebo; Isoniazid; Gastroenterology; Dermatology; Mycobacterium tuberculosis; Tumor necrosis factor alpha; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005706854,0.0004691526,0.001749257,0.0002418545,0.0001964319,0.00001489456,0.0003668129,0.0004014881,0.00003730232],"category_scores_gemma":[0.0002870638,0.0002708358,0.0001782052,0.000291552,0.000375428,0.0001604714,0.0001634544,0.0005618926,0.00001901667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000495124,"about_ca_system_score_gemma":0.00005427335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005115669,"about_ca_topic_score_gemma":0.00002685187,"domain_scores_codex":[0.9937372,0.003766607,0.001473402,0.0005049629,0.0001019349,0.0004159176],"domain_scores_gemma":[0.997519,0.0008260376,0.001207651,0.0002083805,0.00009407163,0.0001448495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07527313,0.001264196,0.881423,0.00005267857,0.009182491,0.000346567,0.00307456,0.0002670748,0.01637613,0.00007399317,0.001603299,0.01106285],"study_design_scores_gemma":[0.1122549,0.001174104,0.8365585,0.0004064256,0.005054803,0.001566051,0.0001745055,0.000021771,0.03884483,0.00007820939,0.003195426,0.0006703841],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900101,0.001906937,0.00002631629,0.006505799,0.0001318486,0.0005275372,0.0006843412,0.00001899061,0.0001880899],"genre_scores_gemma":[0.9976742,0.001116451,0.0002529926,0.0006734616,0.00005134575,0.000006089943,0.0001126241,0.00004092353,0.00007194377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04486448,"threshold_uncertainty_score":0.9999744,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02832032910597882,"score_gpt":0.2563176746490313,"score_spread":0.2279973455430525,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}